Molecular Diagnostics
Molecular Diagnostics
批准号:
9253367
负责人:
JAMES Lewis ZEHNDER
金额:
$23.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2019-03-31
关键词:
Animal ModelB cell repertoireBiologicalBiological AssayBone Marrow TransplantationChemistryClinicalCost AnalysisCustomDataDetection of Minimal Residual DiseaseDiagnosticDiseaseDisease MarkerDisease ProgressionEarly DiagnosisEnsureGene RearrangementGoalsGoldImmuneInstructionInterventionInvestigational TherapiesMassive Parallel SequencingMethodsMolecularMolecular AnalysisMolecular ProfilingMonitorPatientsPerformancePlayProceduresProgram Research Project GrantsRecurrenceRelapseResearch PersonnelResidual NeoplasmReverse Transcriptase Polymerase Chain ReactionRoleServicesSpecimenTechnologyTestingTimeTissue SampleTransplantationTreatment outcomeWorkclinical caregene translocationhematopoietic cell transplantationimprovedinnovationleukemia/lymphomamolecular diagnosticsmolecular markermolecular pathologynext generationnext generation sequencingnovelpreclinical studyprogramsreconstitutionresponsetooltreatment group
中文摘要
分子病理学核心的作用是通过提供专门的分子生物学分析来有效评估疾病状态,患者和动物模型对治疗反应的分子基础,以及移植干预后免疫重建的分析,来支持计划项目资助的研究人员。这个核心提供的服务是那些扩展的服务
英文摘要
The role of the Molecular Pathology Core is to support investigators in the Program Project Grant by providing dedicated molecular biological analyses for effective assessment of disease states, the molecular basis of response to therapy both in patients and in animal models, and the analysis of immune reconstitution following transplant interventions. The services provided by this Core are those that extend
beyond routine preclinical studies and standard clinical care. This Core provides molecular testing for projects that monitor treatment outcomes, detect eariy disease recurrence and minimal disease states.
Rapid and quantitative assessment of experimental therapies is necessary for accelerated and accurate analyses of potential efficacy. Quantitative assessment of minimal residual disease will be performed using TaqMan chemistry for a robust assessment of disease response and potential recurrence on clinical
specimens. The core will utilize novel, massively parallel next generation sequencing technology in addition to the standard real-time PCR methods to improve detection of minimal residual disease and provide an assessment of immune reconstitution. The centralized performance of the molecular procedures by this Core will avoid duplication of efforts in the program and ensure timely, efficient and consistently high quality
results.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Diagnostics
-
批准号:8476451
-
项目类别:
-
资助金额:$23.95万
-
财政年份:1997
-
负责人:JAMES Lewis ZEHNDER
-
依托单位:
BIOLOGY OF THE CELL ADHESION MOLECULE CD31
-
批准号:3087822
-
项目类别:
-
资助金额:$9.12万
-
财政年份:1992
-
负责人:JAMES Lewis ZEHNDER
-
依托单位:
BIOLOGY OF THE CELL ADHESION MOLECULE CD31
-
批准号:2210269
-
项目类别:
-
资助金额:$9.19万
-
财政年份:1992
-
负责人:JAMES Lewis ZEHNDER
-
依托单位:
BIOLOGY OF THE CELL ADHESION MOLECULE CD31
-
批准号:3087823
-
项目类别:
-
资助金额:$9.19万
-
财政年份:1992
-
负责人:JAMES Lewis ZEHNDER
-
依托单位:
Molecular Diagnostics
-
批准号:9071315
-
项目类别:
-
资助金额:$23.95万
-
财政年份:--
-
负责人:JAMES Lewis ZEHNDER
-
依托单位:
Molecular Diagnostics
-
批准号:8744817
-
项目类别:
-
资助金额:$23.23万
-
财政年份:--
-
负责人:JAMES Lewis ZEHNDER
-
依托单位:
海外基金